Recognition of impairment losses on investment securities
First written in FY2020-Q3. . Latest entry: FY2025.
The whole theme swung hardest in 2023: 1 of 7 companies on the "Worse" side.
5 other companies' latest entry also says "Other".
- FY2025Update on full-year impairment lossAnnual report
「The Company recognized an impairment loss of ¥2 million on securities, comprising ¥2 million on shares classified as other securities.」
The Company recorded a full-year impairment loss on investment securities of ¥2 million. - FY2023-Q3Update to third-quarter impairment lossesAnnual report
「Impairment loss on investment securities ¥11 million －」
The Company recorded no impairment loss on investment securities during the cumulative third quarter, compared with ¥11 million in the year-earlier period. - FY2022Update on full-year impairment lossAnnual report
「During the consolidated fiscal year, impairment losses of ¥12 million were recognized on securities, consisting of ¥12 million on shares classified as other securities.」
The full-year impairment loss on investment securities was ¥12 million, down from ¥14 million in the previous fiscal year. - FY2022-Q3Update to third-quarter impairment lossesAnnual report
「Impairment loss on investment securities － ¥11 million Impairment loss on shares of associates － ¥6 million」
During the cumulative third quarter, the Company recorded an impairment loss on investment securities of ¥11 million and an impairment loss on shares of associates of ¥6 million. - FY2022-Q2Update on the second-quarter impairment lossAnnual report
「Impairment loss on investment securities － ¥2 million Impairment loss on shares of associates － ¥5 million」
During the cumulative second quarter, the Company recorded an impairment loss on investment securities of ¥2 million and an impairment loss on shares of associates of ¥5 million. - FY2021Update on full-year impairment lossAnnual report
「The Company recognized an impairment loss of ¥14 million on securities, comprising ¥14 million on shares classified as other securities.」
The full-year impairment loss on investment securities was ¥14 million, down from ¥211 million in the previous year. - FY2020Update on full-year impairment lossAnnual report
「During the current consolidated fiscal year, the Company recognized impairment losses of ¥211 million on securities, comprising ¥211 million on shares classified as other securities.」
The full-year impairment loss on investment securities was ¥211 million, updated from ¥124 million for the cumulative third quarter. - FY2020-Q3First statedAnnual report
「Impairment loss on investment securities － ¥124 million」
During the first 3 quarters of the current consolidated fiscal year, the Company recorded an impairment loss on investment securities of ¥124 million as an extraordinary loss.